Tulba, Sherwin O.
HRN: 23-82-88 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/06/2023
CEFTRIAXONE 1G (VIAL)
10/06/2023
10/13/2023
IV
3gms
OD
Meningitic Dose; Brain Abscess
Waiting Final Action
Indication: Empiric Type of Infection: Central Nervous System Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes